Medicine

Novartis annonce une nouvelle stratégie pour fournir des traitements innovants à plus de patients en Afrique subsaharienne

Summary: 
  • Cette stratégie s’inscrit dans la continuité des Novartis Access Principles, qui visent à intégrer systématiquement des stratégies d’accès dans la manière dont l’entreprise recherche, développe et commercialise ses médicaments dans le monde entier

  • Une unité récemment formée pour l’Afrique subsaharienne déploiera des approches innovantes pour atteindre davantage de patients, sur l’ensemble de la pyramide des revenus

  • Novartis se base sur ses activités établies dans le domaine du paludisme, du cancer, de la drépanocytose et des maladies cardiovasculaires, ainsi que sur ses modèles d’entreprises sociales qui ont fait leurs preuves sur ce continent

  • L’Afrique supporte un quart du fardeau mondial des maladies, mais seuls 3% des professionnels de la santé dans le monde sont basés sur ce continent. Par ailleurs, moins de 1% des dépenses de santé mondiales sont réalisées en Afrique1.

Press Release
  • Cette stratégie s’inscrit dans la continuité des Novartis Access Principles, qui visent à intégrer systématiquement des stratégies d’accès dans la manière dont l’entreprise recherche, développe et commercialise ses médicaments dans le monde entier

  • Une unité récemment formée pour l’Afrique subsaharienne déploiera des approches innovantes pour atteindre davantage de patients, sur l’ensemble de la pyramide des revenus

  • Novartis se base sur ses activités établies dans le domaine du paludisme, du cancer, de la drépanocytose et des maladies cardiovasculaires, ainsi que sur ses modèles d’entreprises sociales qui ont fait leurs preuves sur ce continent

  • L’Afrique supporte un quart du fardeau mondial des maladies, mais seuls 3% des professionnels de la santé dans le monde sont basés sur ce continent. Par ailleurs, moins de 1% des dépenses de santé mondiales sont réalisées en Afrique1.

Novartis Announces New Strategy to Provide Innovative Medicines to More Patients in Sub-Saharan Africa

Summary: 
  • The strategy is aligned with the Novartis Access Principles, which aim to systematically integrate access strategies in how the company researches, develops and delivers medicines globally

  • A newly formed sub-Saharan Africa unit will deploy innovative approaches to increase patient reach across the full income pyramid

  • Novartis is building on its established activities in malaria, cancer, sickle cell and cardiovascular diseases as well as proven social business models on the continent

  • A quarter of the global disease burden is located in Africa, but only 3% of the world’s health workers are based on the continent and the share of the world’s health expenditure for Africa is below 1%.1

Press Release
  • The strategy is aligned with the Novartis Access Principles, which aim to systematically integrate access strategies in how the company researches, develops and delivers medicines globally

  • A newly formed sub-Saharan Africa unit will deploy innovative approaches to increase patient reach across the full income pyramid

  • Novartis is building on its established activities in malaria, cancer, sickle cell and cardiovascular diseases as well as proven social business models on the continent

  • A quarter of the global disease burden is located in Africa, but only 3% of the world’s health workers are based on the continent and the share of the world’s health expenditure for Africa is below 1%.1

The ROI of Health and Well-Being: Business Investment in Healthier Communities

Article

The World Economic Forum estimates a cumulative economic output loss of $47 trillion over the next two decades from noncommunicable diseases, like cancer, diabetes, and mental health. As businesses acknowledge the importance of health in the workplace, they are also beginning to recognize the relationship between their employees' health and the communities where their employees and customers live.

Meet Amgen Scholars Alumni Alex B. Munster

"The freedom, trust and respect my supervisor and lab colleagues showed toward me allowed me to flourish on my own, and has suitably prepared me for PhD life after I graduate–and my future career as a physician scientist."
Blog

Dorset, UK

Host University: Kyoto University

Home University: University of Cambridge

Amgen Scholar Year: 2016

Major: Medicine

Expected Graduation: 2019

Journey to Science

How did you become interested in science?

Pricing Our Medicines to Help Ensure Patient Access

Article

We know there is significant frustration in the US regarding the cost of healthcare – including prescription medicines. We take this very seriously, as evidenced by our pricing track record. In fact, the launch price of our six most recently introduced new medicines were priced similarly or less than the market leader. This illustrates our commitment to appropriately balance reward for our innovation and ensure broadest patient access.

Meet Amgen Scholars Alumni Rana Tahir Rasool

"Conducting research at the University of Cambridge has given me the skills and confidence to work independently in my research field."
Blog

Lahore, Pakistan

Host University: University of Cambridge

Home University: University of Zagreb

Amgen Scholar Year: 2016

Major: Medicine

Expected Graduation: 2018

Journey to Science

What inspired you to major in science?

Dr. Margaret Chan & Michael Bloomberg: Political Will Needed to Win Fight Against Noncommunicable Diseases

Blog

Originally posted on WHO

Our modern way of life is a major cause of many noncommunicable diseases (NCDs). Initially lifestyle diseases of industrialized countries, they have long since reached developing countries and lead to serious consequences and tremendous costs for health care systems worldwide. Above all, the implementation of sustainable solutions calls for political action.

Bristol-Myers Squibb Supports Haitian Hurricane Relief Efforts

Press Release

NEW YORK, October 10, 2016 /3BL Media/ -- Bristol-Myers Squibb and the Bristol-Myers Squibb Foundation are supporting emergency relief effort in Haiti following the Category 4 hurricane which hit the island on October 4, destroying homes and crops, flooding streets and cutting off transportation across the island. Haiti is the poorest country in the Western Hemisphere and has been plagued by natural disasters over the past decade.

The company is donating $600,000 in medicines to help the people of Haiti.

Apply to be an Amgen Scholar at Kyoto University

Blog

Kyoto University

PROGRAM DATES
July 1 - August 26, 2016

APPLICATION DEADLINE
February 1, 2016

Apply to be an Amgen Scholar

Applications to be an Amgen Scholar are provided by and processed at each participating host institution. Follow the link above to find this institution’s application.

Sanofi – Transport of Medicine and Environmental Preservation

Multimedia with summary

Sanofi has developed its supply chain of medicine towards a bigger environmental preservation for over 10 years.

Watch more Sanofi videos! Vist our YouTube page at SanofiTV

Pages

Subscribe to Medicine